✦ LIBER ✦

Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy

✍ Scribed by Liang Cheng; Thomas J. Sebo; Jeff Slezak; Thomas M. Pisansky; Erik J. Bergstralh; Roxann M. Neumann; Kenneth A. Iczkowski; Horst Zincke; David G. Bostwick

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 535 KB
Volume: 83
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19981115)83:10<2164::aid-cncr15>3.0.co;2-i

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Salvage radical prostatectomy is a treatment option for patients with recurrent cancer following radiation therapy. This study was conducted to identify predictors of survival for patients treated with salvage radical prostatectomy.

METHODS.

The authors studied 86 prostate carcinoma patients who underwent salvage radical prostatectomy for locally persistent or recurrent prostate carcinoma at Mayo Clinic between 1967 and 1996. The mean interval from radiation therapy to biopsy-proven recurrence was 3.7 years (range, 6 months to 17 years). Patient age at surgery ranged from 51 to 78 years (median, 66 years). The mean follow-up after surgery was 5.8 years (range, 1.0 -15.2 years). Cox proportional hazards models were used to identify clinical and pathologic factors associated with distant metastasis free survival and cancer specific survival.

RESULTS.

Actuarial distant metastasis free survival, cancer specific survival, and overall survival were 83%, 91%, and 85% at 5 years and 69%, 64%, and 54% at 10 years, respectively. In multivariate analysis, radical prostatectomy Gleason score and DNA ploidy were independent predictors of distant metastasis free survival and cancer specific survival.

CONCLUSIONS.

Postirradiation Gleason score and DNA ploidy were highly predictive of the clinical outcomes of patients treated by salvage radical prostatectomy after radiation therapy.

📜 SIMILAR VOLUMES

Delayed/salvage radiation therapy in pat

Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy: A long term follow-up

✍ Eitan Medini; Iris Medini; Pratap K. Reddy; Seymour H. Levitt 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

## BACKGROUND. In this article the authors report an analysis and long term results of delayedlsalvage radiation therapy administered to asymptomatic patients who had an elevated prostate specific antigen (PSA) level, many months to many years after radical prostatectomy. ## METHODS. During 198

Pathologic seminal vesicle invasion afte

Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma : Effect of early adjuvant radiation therapy on biochemical control

✍ Richard K. Valicenti; Leonard G. Gomella; Mohammed Ismail; S. Grant Mullholland; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Background: The authors evaluated the effect of postoperative radiation therapy on freedom from biochemical failure (bned) in men with prostate carcinoma who had pathologic seminal vesicle invasion after radical prostatectomy and negative pelvic lymph node dissection (pt3cn0). ## Methods: Betw

Biochemical outcome after radical prosta

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

✍ Anthony V. D'Amico; Richard Whittington; S. Bruce Malkowicz; Kerri Cote; Marian 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative long‐term efficacy of radical prostatectomy (RP) versus conventional‐dose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A

Assessment of outcome prediction models

Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy

✍ Anthony V. D'Amico; April Desjardin; Arnold Chung; Ming-Hui Chen; Delray Schultz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

or neoadjuvant hormonal or radiation therapy were excluded. Akaike's Information Criterion (AIC) and Schwartz Bayesian Criterion (SBC) estimates, which are com-1 Joint Center for Radiation Therapy, Harvard parative measures, were calculated for each clinical staging system. Pairwise com-Medical Scho

Cancer-specific survival and predictors

Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy

✍ Fernando P. Secin; Fernando J. Bianco Jr.; Andrew J. Vickers; Victor Reuter; Tho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme

A comparison of external beam radiation

A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution

✍ Alvaro A. Martinez; Jose A. Gonzalez; Andrew K. Chung; Larry L. Kestin; Mamtha B 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Background: The authors retrospectively reviewed their institution's long term experience treating a group of comparably staged low risk prostate carcinoma patients with either radical prostatectomy or external beam radiation therapy (rt) to determine whether the method of treatment resulted in